化合物 Taselisib|T1999|TargetMol

Taselisib
1282512-48-4

￥247 1mg 起订

￥346 2mg 起订

￥578 5mg 起订

上海更新日期：2024-12-12

TargetMol中国（陶术生物）

VIP3年

联系人：邵小姐

手机：4008200310 拨打

邮箱：marketing@tsbiochem.com

产品详情:

中文名称：: 化合物 Taselisib

英文名称：: Taselisib

CAS号：: 1282512-48-4

品牌：: TargetMol

产地：: 美国

保存条件：: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

纯度规格：: 99.62%

产品类别：: 抑制剂

货号：: T1999

Product Introduction

Bioactivity

名称	Taselisib
描述	Taselisib (GDC-0032) is an orally bioavailable inhibitor of the class I phosphatidylinositol 3-kinase (PI3K) alpha isoform (PIK3CA), with potential antineoplastic activity.
细胞实验	GDC-0032 is dissolved in DMSO. Cells are seeded in replicates of 6 in 96-well plates with 500 to 5,000 cells/well overnight and then treated with GDC-0032. After 4 days, the media are removed and the cells are fixed with 4% glutaraldehyde for 30 minutes. Fixed cells are stained with 0.1% crystal violet for 2 minutes, then washed, and dissolved in 10% acetic acid.
激酶实验	Characterization of Biochemical and Cellular Activity in Vitro: Enzymatic activity of the class I PI3K isoforms is measured using a fluorescence polarization assay that monitors formation of the product 3,4,5-inositoltriphosphate molecule as it competes with fluorescently labeled PIP3 for binding to the GRP-1 pleckstrin homology domain protein. An increase in phosphatidyl inositide-3-phosphate product results in a decrease in fluorescence polarization signal as the labeled fluorophore is displaced from the GRP-1 protein binding site. Class I PI3K isoforms are expressed and purified as heterodimeric recombinant proteins. Tetramethylrhodamine-labeled PIP3 (TAMRA-PIP3), di-C8-PIP2, and PIP3 detection reagents are purchased from Echelon Biosciences. PI3Kα is assayed under initial rate conditions in the presence of 10 mM Tris (pH 7.5), 25 μM ATP, 9.75 μM PIP2, 5% glycerol, 4 mM MgCl2, 50 mM NaCl, 0.05% (v/v) Chaps, 1 mM dithiothreitol, and 2% (v/v) DMSO at 60 ng/mL. After assay for 30 min at 25 °C, reactions are terminated with a final concentration of 9 mM EDTA, 4.5 nM TAMRA-PIP3, and 4.2 μg/mL GRP-1 detector protein before reading fluorescence polarization on an Envision plate reader. IC50 values are calculated from the fit of the dose-response curves to a 4-parameter equation. Each reported value is an average of three experiments, and all have a standard deviation less than one geometric mean.
体外活性	GDC-0032与氟维司群联用,增强氟维司群活性,导致肿瘤消退和肿瘤生长延迟（91％肿瘤生长抑制（TGI））.此外,GDC-0032与他莫昔芬联用,增强他莫昔芬在体内的效力,GDC-0032的肿瘤生长抑制率为102％.GDC-0032药代动力学大约与剂量成比例并且与时间无关,平均t1/2为40小时.
体内活性	临床前期数据表明,GDC-0032具有增加PI3Kα同种型（PIK3CA）突变体和HER2扩增的癌细胞系的活性。GDC-0032抑制MCF7-neo/HER2 细胞增殖,IC50为2.5 nM。GDC-0032是I类PI3Kα,δ和γ同种型的口服生物可利用的,有效的和选择性的抑制剂,相对于PI3Kα同种型,其对PI3Kβ同种型抑制率低30倍。
存储条件	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
溶解度	DMSO : 40 mg/mL (86.86 mM), Heating is recommended. Ethanol : < 1 mg/mL (insoluble or slightly soluble)
关键字	RG7604 \| inhibit \| Taselisib \| Inhibitor \| GDC0032 \| Phosphoinositide 3-kinase \| GDC 0032 \| RG 7604 \| PI3K
相关产品	Cyclamic acid sodium \| Urea \| Benzenesulfonamide \| Quercetin Dihydrate \| Apilimod \| pNNP \| Tioxolone \| Myricetin \| Isoprenaline hydrochloride \| Erucic acid \| Orthanilamide \| Hydrochlorothiazide
相关库	抑制剂库 \| 经典已知活性库 \| 抗癌活性化合物库 \| 已知活性化合物库 \| 激酶抑制剂库 \| 抗衰老化合物库 \| 抗肺癌化合物库 \| 药物功能重定位化合物库 \| 抗癌临床化合物库 \| 抗癌药物库

RG-7604|||GDC-0032|TargetMol

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿，致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区，已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库，以及多种类型的生化试剂产品，包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等，此外，我们还建设有CADD（计算机辅助药物设计）研究中心、药理实验室、药化合成平台三大技术中心，全方位满足客户的定制需求。凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持，我们将有效帮助您缩短研发周期，取得更成功的结果。

成立日期	(12年)
注册资本	566.265100万人民币
员工人数	100-500人
年营业额	￥ 1亿以上
经营模式	贸易,工厂,试剂,定制,服务
主营行业	天然产物,生化试剂,分子生物学,分子砌块,生物技术服务